Dr. Vikram Anant Rajadnya et al. 2025. COMPARING BRANDS OF GLIBENCLAMIDE(5MG) AND METFORMIN (500MG) SUSTAINED RELEASE(SR) FIXED DOSE COMBINTION (FDC) PREPARATIONS IN HIGHLY COST SENSITIVE INDIAN PATIENTS SCENARIO. Journal of Population Therapeutics and Clinical Pharmacology. 32, 8 (Sep. 2025), 1271–1275. DOI:https://doi.org/10.53555/z6p5cc45.